Top Markets
Coin of the day
QuantRx Biomedical Corporation QuantRx Biomedical Corporation

QuantRx Biomedical Corporation

QTXB
주식 순위 #40578
QuantRx Biomedical Corporation is engaged in the creation and marketing of its... QuantRx Biomedical Corporation is engaged in the creation and marketing of its patented miniature pads (PADs) and related over-the-counter (OTC) products within the United States. Additionally, the company is developing genomic diagnostic tools for the laboratory market, leveraging its proprietary lateral flow technologies, including the RapidSense single-step lateral flow test. The company's PAD products are designed to address a range of medical conditions such as hemorrhoids, mild vaginal infections, urinary incontinence, menstrual hygiene, and other general medical needs. Key offerings include InSync, an interlabial pad for feminine hygiene. Another significant product is the Unique miniform, which comes in two forms: a medicated pad providing temporary relief from the itching and discomfort associated with hemorrhoids and minor vaginal infections, and an unmedicated pad for daily management of light urinary, vaginal, or anal leakage. Other treated miniform products are also part of their portfolio. Established in 1986, QuantRx Biomedical Corporation is headquartered in Tualatin, Oregon.
주가
$0.0005
마지막 동기화: 2025-04-08
시가총액
$118.05K
변동 (1일)
0.00%
변동 (1년)
0.00%
국가
US
거래 QuantRx Biomedical Corporation (QTXB)

카테고리

QuantRx Biomedical Corporation (QTXB)의 P/S 비율
2026 기준 P/S 비율 TTM: 0
QuantRx Biomedical Corporation의 최신 재무 보고서와 주가에 따르면 현재 P/S 비율(TTM)은 0입니다. 2026년 말 기준 P/S 비율은 0였습니다.
QuantRx Biomedical Corporation의 P/S 비율 기록 (2026 ~ 2026)
매년 말 P/S 비율
연도 P/S 비율 변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 P/S 비율
회사 P/S 비율 P/S 비율 차이 국가
11.31 -
US
2.57 -
FR
- -
JP
2.81 -
US
- -
CH